Impact of COVID-19 Vaccination in the United States
Overview of the Pandemic
As the SARS-CoV-2 (COVID-19) pandemic approaches its third year, the toll on human life has been significant, with over a million fatalities reported in the United States alone. The introduction of several vaccines has provided a crucial tool in transitioning from a pandemic to an endemic mindset.
Efficacy of the Pfizer-BioNTech Vaccine
A recent study has focused on the public health impact of the Pfizer-BioNTech vaccine (BNT162b2), the first vaccine administered in the US. Before the vaccination campaign commenced, approximately 33 million Americans aged 12 and older had tested positive for the SARS-CoV-2 virus and recovered. This figure served as a foundation for further analysis.
Economic and Health Benefits from Vaccination
The study estimated that without the vaccination efforts, around 59.5 million individuals would have contracted the virus, potentially leading to an economic loss of nearly $279 billion. However, due to the vaccination initiative, it is projected that over 111,000 deaths and nearly 700,000 hospitalizations were prevented, resulting in savings of approximately $30.4 billion in healthcare costs.
Research Findings and Conclusions
Researchers concluded that the Pfizer-BioNTech COVID-19 vaccine significantly influenced public health in the US during 2021. It is estimated to have averted millions of symptomatic COVID-19 cases, thousands of hospitalizations, and deaths, while also generating billions in economic value for society.
References
Di Fusco M, Marczell K, Deger KA, Moran MM, Wiemken TL, Cane A, de Boisvilliers S, Yang J, Vaghela S, and Roiz J. (2022) “Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States” Journal of Medical Economics 25(1): 605-617; DOI:10.1080/13696998.2022.2071427 [Link to study](https://www.tandfonline.com/doi/full/10.1080/13696998.2022.2071427).
News release: Nearly 700,000 US hospitalizations and 110,000 deaths prevented from the Pfizer-BioNTech COVID-19 vaccine, national study finds. [Link to news release](https://www.eurekalert.org/news-releases/952615).
Photo by Miguel Á. Padriñán at Pexels.